930 related articles for article (PubMed ID: 16847921)
21. Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low compliance bladder.
Kaga K; Yamanishi T; Kaga M; Fuse M; Kamasako T; Ishizuka M
Int J Urol; 2020 Oct; 27(10):899-904. PubMed ID: 32767525
[TBL] [Abstract][Full Text] [Related]
22. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.
Reitz A; Stöhrer M; Kramer G; Del Popolo G; Chartier-Kastler E; Pannek J; Burgdörfer H; Göcking K; Madersbacher H; Schumacher S; Richter R; von Tobel J; Schurch B
Eur Urol; 2004 Apr; 45(4):510-5. PubMed ID: 15041117
[TBL] [Abstract][Full Text] [Related]
23. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
[TBL] [Abstract][Full Text] [Related]
24. Effects of intravesical electrical stimulation therapy on urodynamic patterns for children with spina bifida: a 10-year experience.
Choi EK; Hong CH; Kim MJ; Im YJ; Jung HJ; Han SW
J Pediatr Urol; 2013 Dec; 9(6 Pt A):798-803. PubMed ID: 23177928
[TBL] [Abstract][Full Text] [Related]
25. [Disorders of micturition following intervertebral disk operations. Neurologic diagnosis and therapy].
Kiesswetter H; Wöber L
Wien Klin Wochenschr; 1987 Aug; 99(16):566-72. PubMed ID: 3660842
[TBL] [Abstract][Full Text] [Related]
26. Urodynamics findings in transverse myelitis patients with lower urinary tract symptoms: Results from a tertiary referral urodynamic center.
Gliga LA; Lavelle RS; Christie AL; Coskun B; Greenberg BM; Carmel ME; Lemack GE
Neurourol Urodyn; 2017 Feb; 36(2):360-363. PubMed ID: 26587780
[TBL] [Abstract][Full Text] [Related]
27. Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: a randomized, placebo-controlled, double-blind study.
Lazzeri M; Calò G; Spinelli M; Guerrini R; Salvadori S; Beneforti P; Sandri S; Regoli D; Turini D
Urology; 2003 May; 61(5):946-50. PubMed ID: 12736013
[TBL] [Abstract][Full Text] [Related]
28. Detrusor Acontractility after Acute Spinal Cord Injury-Myth or Reality?
Bywater M; Tornic J; Mehnert U; Kessler TM
J Urol; 2018 Jun; 199(6):1565-1570. PubMed ID: 29352989
[TBL] [Abstract][Full Text] [Related]
29. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease.
Kabay S; Canbaz Kabay S; Cetiner M; Mestan E; Sevim M; Ayas S; Ozden H; Ozisik Karaman H
Urology; 2016 Jan; 87():76-81. PubMed ID: 26436213
[TBL] [Abstract][Full Text] [Related]
30. Is it possible to use urodynamic variables to predict upper urinary tract dilatation in children with neurogenic bladder-sphincter dysfunction?
Wang QW; Wen JG; Song DK; Su J; Che YY; Zhang P; Du AM; Wang DX; Zhu QH; Wei JX
BJU Int; 2006 Dec; 98(6):1295-300. PubMed ID: 17034510
[TBL] [Abstract][Full Text] [Related]
31. Detrusor Pressures Change with Repeat Filling Cystometry in Myelodysplastic Children with Neurogenic Lower Urinary Tract Dysfunction.
Ergun R; Sekerci CA; Tanidir Y; Atmis B; Gemici A; Yucel S
J Urol; 2021 Feb; 205(2):577-585. PubMed ID: 32897763
[TBL] [Abstract][Full Text] [Related]
32. Detrusor overactivity in patients with cauda equina syndrome.
Kim SY; Kwon HC; Hyun JK
Spine (Phila Pa 1976); 2014 Jul; 39(16):E955-61. PubMed ID: 24831504
[TBL] [Abstract][Full Text] [Related]
33. [Overactive bladder: urodynamic characteristics of detrusor overactivity due to the etiology of low urinary tract dysfun- ction].
Philippova ES; Bazhenov IV; Ziryanov AV; Zhuravlev VN
Urologiia; 2021 Jun; (3):39-44. PubMed ID: 34251099
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of electrical stimulation of the neurogenic bladder: results of a two-year follow-up study.
Radziszewski K
NeuroRehabilitation; 2013; 32(4):867-73. PubMed ID: 23867413
[TBL] [Abstract][Full Text] [Related]
35. Distinguishing neurogenic from non-neurogenic detrusor overactivity: a urodynamic assessment of lower urinary tract symptoms in patients with and without Parkinson's disease.
Defreitas GA; Lemack GE; Zimmern PE; Dewey RB; Roehrborn CG; O'Suilleabhain PE
Urology; 2003 Oct; 62(4):651-5. PubMed ID: 14550436
[TBL] [Abstract][Full Text] [Related]
36. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder.
Amarenco G; Ismael SS; Even-Schneider A; Raibaut P; Demaille-Wlodyka S; Parratte B; Kerdraon J
J Urol; 2003 Jun; 169(6):2210-5. PubMed ID: 12771752
[TBL] [Abstract][Full Text] [Related]
37. [Pathophysiology of urge, stress, and mixed incontinence].
Schumacher S
Urologe A; 2005 Mar; 44(3):239-43. PubMed ID: 15726315
[TBL] [Abstract][Full Text] [Related]
38. The results of three times repeated filling cystometry and pressure flow studies in children with non-neurogenic lower urinary tract dysfunction.
Ergun R; Sekerci CA; Tanidir Y; Ozturk Nİ; Tarcan T; Yucel S
Neurourol Urodyn; 2022 Jun; 41(5):1157-1164. PubMed ID: 35419875
[TBL] [Abstract][Full Text] [Related]
39. A pilot randomized-controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction.
Welk B; Hickling D; McKibbon M; Radomski S; Ethans K
Neurourol Urodyn; 2018 Nov; 37(8):2810-2817. PubMed ID: 30168626
[TBL] [Abstract][Full Text] [Related]
40. Retrospective clinic and urodynamic study in the neurogenic bladder dysfunction caused by human T cell lymphotrophic virus type 1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Troisgros O; Barnay JL; Darbon-Naghibzadeh F; Olive P; René-Corail P
Neurourol Urodyn; 2017 Feb; 36(2):449-452. PubMed ID: 26756420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
